PMC:7170368 / 5093-6289
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
187 | 24-32 | Species | denotes | patients | Tax:9606 |
188 | 69-75 | Species | denotes | People | Tax:9606 |
189 | 123-131 | Species | denotes | patients | Tax:9606 |
190 | 168-176 | Species | denotes | patients | Tax:9606 |
191 | 334-342 | Species | denotes | patients | Tax:9606 |
192 | 436-444 | Species | denotes | patients | Tax:9606 |
193 | 534-542 | Species | denotes | patients | Tax:9606 |
194 | 553-561 | Species | denotes | patients | Tax:9606 |
195 | 625-633 | Species | denotes | patients | Tax:9606 |
196 | 644-652 | Species | denotes | patients | Tax:9606 |
197 | 771-779 | Species | denotes | patients | Tax:9606 |
198 | 818-826 | Species | denotes | patients | Tax:9606 |
199 | 980-988 | Species | denotes | patients | Tax:9606 |
200 | 1108-1116 | Species | denotes | patients | Tax:9606 |
201 | 706-713 | Chemical | denotes | calcium | MESH:D002118 |
202 | 15-23 | Disease | denotes | COVID-19 | MESH:C000657245 |
203 | 149-161 | Disease | denotes | hypertension | MESH:D006973 |
204 | 890-905 | Disease | denotes | type 2 diabetes | MESH:D003924 |
205 | 916-938 | Disease | denotes | coronary heart disease | MESH:D003324 |
206 | 940-943 | Disease | denotes | CHD | |
207 | 967-979 | Disease | denotes | hypertensive | MESH:D006973 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T11 | 925-930 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
T12 | 1090-1095 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T14 | 925-930 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
T15 | 1090-1095 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T41 | 15-23 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T42 | 149-161 | Disease | denotes | hypertension | http://purl.obolibrary.org/obo/MONDO_0005044 |
T43 | 520-523 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T44 | 583-586 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T45 | 611-614 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T46 | 802-805 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T47 | 847-850 | Disease | denotes | ARB | http://purl.obolibrary.org/obo/MONDO_0012733 |
T48 | 890-905 | Disease | denotes | type 2 diabetes | http://purl.obolibrary.org/obo/MONDO_0005148 |
T49 | 897-905 | Disease | denotes | diabetes | http://purl.obolibrary.org/obo/MONDO_0005015 |
T50 | 907-910 | Disease | denotes | T2D | http://purl.obolibrary.org/obo/MONDO_0005148 |
T51 | 916-938 | Disease | denotes | coronary heart disease | http://purl.obolibrary.org/obo/MONDO_0005010 |
T52 | 925-938 | Disease | denotes | heart disease | http://purl.obolibrary.org/obo/MONDO_0005267 |
T53 | 940-943 | Disease | denotes | CHD | http://purl.obolibrary.org/obo/MONDO_0005010 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T32 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T33 | 925-930 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T34 | 925-930 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T35 | 925-930 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T36 | 925-930 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
T37 | 1064-1066 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T38 | 1090-1095 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T39 | 1090-1095 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T50 | 227-249 | Chemical | denotes | antihypertensive drugs | http://purl.obolibrary.org/obo/CHEBI_35674 |
T51 | 244-249 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T52 | 361-377 | Chemical | denotes | antihypertensive | http://purl.obolibrary.org/obo/CHEBI_35674 |
T53 | 483-499 | Chemical | denotes | antihypertensive | http://purl.obolibrary.org/obo/CHEBI_35674 |
T54 | 524-529 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T55 | 587-592 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T56 | 615-620 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T57 | 672-694 | Chemical | denotes | antihypertensive drugs | http://purl.obolibrary.org/obo/CHEBI_35674 |
T58 | 689-694 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T59 | 706-730 | Chemical | denotes | calcium channel blockers | http://purl.obolibrary.org/obo/CHEBI_38215 |
T60 | 706-713 | Chemical | denotes | calcium | http://purl.obolibrary.org/obo/CHEBI_22984|http://purl.obolibrary.org/obo/CHEBI_29320 |
T62 | 754-763 | Chemical | denotes | diuretics | http://purl.obolibrary.org/obo/CHEBI_35498 |
T63 | 806-811 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T64 | 851-856 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T46 | 0-110 | Sentence | denotes | A total of 417 COVID-19 patients were admitted to the Shenzhen Third People’s Hospital as of 23 February 2020. |
T47 | 111-162 | Sentence | denotes | Among these patients, 51 (12.23%) had hypertension. |
T48 | 163-320 | Sentence | denotes | Nine patients (17.6%) with Grade 1hypertension did not take any antihypertensive drugs during hospitalization and were excluded from the subsequent analysis. |
T49 | 321-419 | Sentence | denotes | The other 42 patients (82.4%) receiving antihypertensive therapy were included in further studies. |
T50 | 420-764 | Sentence | denotes | The 42 analyzed patients were divided into two groups based on antihypertensive therapies: the ACEI/ARB group (17 patients) included patients treated with ACEI or ARB drugs, and the non-ACEI/ARB group (25 patients) included patients treated with other antihypertensive drugs, including calcium channel blockers (CCBs), β-blockers and diuretics. |
T51 | 765-945 | Sentence | denotes | Eight patients (32%) in the non-ACEI/ARB group and 5 patients (29.41%)in the ACEI/ARB group had other comorbidities, such as type 2 diabetes (T2D) and coronary heart disease (CHD). |
T52 | 946-1085 | Sentence | denotes | The vast majority of hypertensive patients had received the current therapeutic regimens shown in supplementary Table S1 for over one year. |
T53 | 1086-1196 | Sentence | denotes | The blood pressure of patients was well-controlled with the above therapeutic regimens during hospitalization. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T15 | 149-161 | Phenotype | denotes | hypertension | http://purl.obolibrary.org/obo/HP_0000822 |
T16 | 890-905 | Phenotype | denotes | type 2 diabetes | http://purl.obolibrary.org/obo/HP_0005978 |